Explore Agios Pharmaceuticals' Q4 2024 financial performance, highlighting revenue growth, cash position, and risks. Key insights on PYRUKYND® and market outlook included.
Explore Agios Pharmaceuticals' 8-K filing from February 13, 2025, detailing significant events impacting investors. Stay informed on critical developments affecting AGIO stock.
Explore Agios Pharmaceuticals' 8-K report detailing a significant event on February 10, 2025. Learn about stock info, transparency, and compliance in this critical disclosure.
Explore Agios Pharmaceuticals' latest 8-K filing from Jan 13, 2025, revealing vital updates for investors and stakeholders.
Explore Agios Pharmaceuticals' 8-K filing details for January 3, 2025. Important updates on corporate events, stock performance, and investor insights. Stay informed!